171 related articles for article (PubMed ID: 32750744)
1. Investigation on the metabolic characteristics of isobavachin in Psoralea corylifolia L. (Bu-gu-zhi) and its potential inhibition against human cytochrome P450s and UDP-glucuronosyltransferases.
Xing H; Yang J; Ren K; Qin Z; Wang P; Zhang X; Yao Z; Gonzalez FJ; Yao X
J Pharm Pharmacol; 2020 Dec; 72(12):1865-1878. PubMed ID: 32750744
[TBL] [Abstract][Full Text] [Related]
2. An investigation of the metabolic activity, isozyme contribution, species differences and potential drug-drug interactions of PI-103, and the identification of efflux transporters for PI-103-
Gao L; Qin Z; Zhang B; Yin Z; Zhang X; Yang J
RSC Adv; 2020 Mar; 10(16):9610-9622. PubMed ID: 35497201
[TBL] [Abstract][Full Text] [Related]
3. Characterization of metabolic activity, isozyme contribution and species differences of bavachin, and identification of efflux transporters for bavachin-O-glucuronide in HeLa1A1 cells.
Li Y; Xu C; Xu J; Qin Z; Li S; Hu L; Yao Z; Gonzalez FJ; Yao X
J Pharm Pharmacol; 2020 Dec; 72(12):1771-1786. PubMed ID: 32648321
[TBL] [Abstract][Full Text] [Related]
4. In vitrometabolic mapping of neobavaisoflavone in human cytochromes P450 and UDP-glucuronosyltransferase enzymes by ultra high-performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry.
Xu J; Li M; Yao Z; Zhang Y; Li S; Hu L; Qin Z; Gonzalez FJ; Yao X
J Pharm Biomed Anal; 2018 Sep; 158():351-360. PubMed ID: 29933228
[TBL] [Abstract][Full Text] [Related]
5. Metabolism and disposition of corylifol A from
Li Y; Xu J; Xu C; Qin Z; Li S; Hu L; Yao Z; Gonzalez FJ; Yao X
Xenobiotica; 2020 Aug; 50(8):997-1008. PubMed ID: 32116078
[TBL] [Abstract][Full Text] [Related]
6. Potential Determinants for Metabolic Fates and Inhibitory Effects of Isobavachalcone Involving in Human Cytochrome P450, UDP-Glucuronosyltransferase Enzymes, and Efflux Transporters.
Qin Z; Wang P; Duan S; Wan X; Xing H; Yang J; Zhang X; Yao Z; Yao X
J Pharm Sci; 2021 May; 110(5):2285-2294. PubMed ID: 33610566
[TBL] [Abstract][Full Text] [Related]
7. [Study on metabolic dynamics,metabolic enzyme phenotype and species difference of hepatic and intestinal microsome of psoralidin].
Qin ZF; Zhang BB; Xing H; Wang PL; Yang J; Zhang XJ; Yao ZH; Yao XS
Zhongguo Zhong Yao Za Zhi; 2021 Jul; 46(13):3410-3421. PubMed ID: 34396762
[TBL] [Abstract][Full Text] [Related]
8. Targeted screen for human UDP-glucuronosyltransferases inhibitors and the evaluation of potential drug-drug interactions with zafirlukast.
Oda S; Fujiwara R; Kutsuno Y; Fukami T; Itoh T; Yokoi T; Nakajima M
Drug Metab Dispos; 2015 Jun; 43(6):812-8. PubMed ID: 25834030
[TBL] [Abstract][Full Text] [Related]
9. Glucuronidation of bavachinin by human tissues and expressed UGT enzymes: Identification of UGT1A1 and UGT1A8 as the major contributing enzymes.
Lv X; Hou J; Xia YL; Ning J; He GY; Wang P; Ge GB; Xiu ZL; Yang L
Drug Metab Pharmacokinet; 2015 Oct; 30(5):358-65. PubMed ID: 26320626
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferases by MAM-2201 in human liver microsomes.
Kong TY; Kim JH; Kwon SS; Cheong JC; Kim HS; In MK; Lee HS
Arch Pharm Res; 2017 Jun; 40(6):727-735. PubMed ID: 28484907
[TBL] [Abstract][Full Text] [Related]
11. Potential metabolism determinants and drug-drug interactions of a natural flavanone bavachinin.
Li X; Xing H; Qin Z; Yang J; Wang P; Zhang X; Yao Z; Yao X
RSC Adv; 2020 Sep; 10(58):35141-35152. PubMed ID: 35515695
[TBL] [Abstract][Full Text] [Related]
12. In Vitro Inhibitory Effects of Synthetic Cannabinoid EAM-2201 on Cytochrome P450 and UDP-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes.
Kong TY; Kwon SS; Cheong JC; Kim HS; Kim JY; Lee HS
Molecules; 2018 Apr; 23(4):. PubMed ID: 29659506
[TBL] [Abstract][Full Text] [Related]
13. Tissue and species differences in the glucuronidation of glabridin with UDP-glucuronosyltransferases.
Guo B; Fang Z; Yang L; Xiao L; Xia Y; Gonzalez FJ; Zhu L; Cao Y; Ge G; Yang L; Sun H
Chem Biol Interact; 2015 Apr; 231():90-7. PubMed ID: 25765239
[TBL] [Abstract][Full Text] [Related]
14. Regioselective glucuronidation of the isoflavone calycosin by human liver microsomes and recombinant human UDP-glucuronosyltransferases.
Ruan JQ; Yan R
Chem Biol Interact; 2014 Sep; 220():231-40. PubMed ID: 25044472
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the in vitro/in vivo drug interaction potential of BST204, a purified dry extract of ginseng, and its four bioactive ginsenosides through cytochrome P450 inhibition/induction and UDP-glucuronosyltransferase inhibition.
Zheng YF; Bae SH; Choi EJ; Park JB; Kim SO; Jang MJ; Park GH; Shin WG; Oh E; Bae SK
Food Chem Toxicol; 2014 Jun; 68():117-27. PubMed ID: 24632066
[TBL] [Abstract][Full Text] [Related]
16. AM-2201 Inhibits Multiple Cytochrome P450 and Uridine 5'-Diphospho-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes.
Kim JH; Kwon SS; Kong TY; Cheong JC; Kim HS; In MK; Lee HS
Molecules; 2017 Mar; 22(3):. PubMed ID: 28287454
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory Effects of Selected Antituberculosis Drugs on Common Human Hepatic Cytochrome P450 and UDP-glucuronosyltransferase Enzymes.
Cao L; Greenblatt DJ; Kwara A
Drug Metab Dispos; 2017 Sep; 45(9):1035-1043. PubMed ID: 28663285
[TBL] [Abstract][Full Text] [Related]
18. Metabolic profiling of corylin in vivo and in vitro.
Qin Z; Li S; Yao Z; Hong X; Xu J; Lin P; Zhao G; Gonzalez FJ; Yao X
J Pharm Biomed Anal; 2018 Jun; 155():157-168. PubMed ID: 29631076
[TBL] [Abstract][Full Text] [Related]
19. Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform.
Ma L; Sun J; Peng Y; Zhang R; Shao F; Hu X; Zhu J; Wang X; Cheng X; Zhu Y; Wan P; Feng D; Wu H; Wang G
Drug Metab Dispos; 2012 Apr; 40(4):734-41. PubMed ID: 22238289
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of human UDP-glucuronosyltransferases responsible for the in-vitro glucuronidation of arctigenin.
Xin H; Xia YL; Hou J; Wang P; He W; Yang L; Ge GB; Xu W
J Pharm Pharmacol; 2015 Dec; 67(12):1673-81. PubMed ID: 26407805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
